- Home
- EVF vs CTOR Comparison
EVF vs CTOR Comparison
Compare EVF & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVF
- CTOR
- Stock Information
- Founded
- EVF 1998
- CTOR 2021
- Country
- EVF United States
- CTOR United States
- Employees
- EVF N/A
- CTOR N/A
- Industry
- EVF Investment Managers
- CTOR
- Sector
- EVF Finance
- CTOR
- Exchange
- EVF Nasdaq
- CTOR NYSE
- Market Cap
- EVF 112.0M
- CTOR 89.9M
- IPO Year
- EVF N/A
- CTOR N/A
- Fundamental
- Price
- EVF $6.21
- CTOR $1.22
- Analyst Decision
- EVF
- CTOR Strong Buy
- Analyst Count
- EVF 0
- CTOR 2
- Target Price
- EVF N/A
- CTOR $4.50
- AVG Volume (30 Days)
- EVF 93.3K
- CTOR 169.0K
- Earning Date
- EVF 01-01-0001
- CTOR 02-21-2025
- Dividend Yield
- EVF 10.68%
- CTOR N/A
- EPS Growth
- EVF N/A
- CTOR N/A
- EPS
- EVF 0.94
- CTOR N/A
- Revenue
- EVF N/A
- CTOR N/A
- Revenue This Year
- EVF N/A
- CTOR N/A
- Revenue Next Year
- EVF N/A
- CTOR N/A
- P/E Ratio
- EVF $6.74
- CTOR N/A
- Revenue Growth
- EVF N/A
- CTOR N/A
- 52 Week Low
- EVF $5.20
- CTOR $0.85
- 52 Week High
- EVF $6.84
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- EVF 53.64
- CTOR N/A
- Support Level
- EVF $6.12
- CTOR N/A
- Resistance Level
- EVF $6.22
- CTOR N/A
- Average True Range (ATR)
- EVF 0.05
- CTOR 0.00
- MACD
- EVF 0.00
- CTOR 0.00
- Stochastic Oscillator
- EVF 81.82
- CTOR 0.00
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.